Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study

被引：0
|
作者：
Jong Hyun Tae
Moon Soo Ha
Byung Hoon Chi
In Ho Chang
Tae-Hyoung Kim
Soon Chul Myung
Tuan Thanh Nguyen
Myoungsuk Kim
Kyung-Eun Lee
Yuwon Kim
Hyun-ki Woo
Dae-Sung Kyoung
Hasung Kim
Se Young Choi
机构：
[1] Chung-Ang University Hospital,Department of Urology
[2] Chung-Ang University College of Medicine,Department of Urology
[3] Hyundae General Hospital,Department of Urology, Cho Ray Hospital
[4] Chung-Ang University College of Medicine,Data Science Team
[5] University of Medicine and Pharmacy at Ho Chi,Data Science Team
[6] Evidnet. Co.,undefined
[7] Ltd,undefined
[8] Hanmi Pharm. Co.,undefined
[9] Ltd,undefined
来源：
BMC Urology | / 22卷
关键词：
Drug therapy; Ureteral neoplasms; Survival; Chemotherapy; Population;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy for upper Urothelial Carcinoma
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02) : 114 - 114
  • [22] Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
    Lee, Junho
    Lim, Sung Hee
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 871 - 876
  • [23] Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma
    Chang, Y. H.
    Lin, C. C.
    Hsiao, P. J.
    Chen, G. H.
    Huang, C. P.
    Wu, H. C.
    Yang, C. R.
    Chang, C. H.
    Yeh, S. P.
    BJU INTERNATIONAL, 2015, 115 : 16 - 17
  • [24] Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: Is There Sufficient Evidence? Reply
    Siefker-Radtke, Arlene O.
    Campbell, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) : 2096 - +
  • [25] THE EFFICACY OF ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED UPPER TRACT UROTHELIAL CARCINOMA
    Kim, T. S.
    Rhew, H. Y.
    Kang, S. H.
    Oh, J. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 209 - 210
  • [26] Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial Carcinoma
    Andreev-Drakhlin, Alexander
    Gao, Jianjun
    Siefker-Radtke, Arlene
    EUROPEAN UROLOGY, 2021, 79 (05) : 655 - 656
  • [27] Adjuvant chemotherapy for upper tract urothelial cancer
    Tanday, Sanjay
    LANCET ONCOLOGY, 2017, 18 (02): : E73 - E73
  • [28] Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
    Lee, Yong Seong
    Ha, Moon Soo
    Tae, Jong Hyun
    Chang, In Ho
    Kim, Tae-Hyoung
    Myung, Soon Chul
    Nguyen, Tuan Thanh
    Kim, Myoungsuk
    Lee, Kyung-Eun
    Kim, Yuwon
    Woo, Hyun-ki
    Kyoung, Dae-Sung
    Kim, Hasung
    Choi, Se Young
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] GEMCITABINE-CISPLATIN VERSUS MVAC CHEMOTHERAPY IN UROTHELIAL CARCINOMA: A NATIONWIDE COHORT STUDY
    Choi, Se Young
    Tae, Jong Hyun
    Chi, Byung Hoon
    Chang, In Ho
    Kim, Tae-Hyoung
    Myung, Soon Chul
    Kim, Jung Hoon
    Kim, Jin Wook
    Lee, Yong Seong
    JOURNAL OF UROLOGY, 2023, 209 : E441 - E441
  • [30] Gemcitabine-cisplatin versus MVAC chemotherapy in urothelial carcinoma: A nationwide cohort study
    Choi, S. Y.
    Tae, J. H.
    Chi, B. H.
    Chang, I. H.
    Kim, T. -H
    Myung, S. C.
    Kim, J. H.
    Lee, Y. S.
    Kim, J. W.
    EUROPEAN UROLOGY, 2023, 83 : S784 - S785
12345